MedTrace Logo

Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients

NCT06453993 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-08-27

No results posted yet for this study

Summary

The purpose of this study is to investigate whether exhaled breath can be used to detect and monitor esophageal cancer.

Conditions

  • Esophageal Cancer

Interventions

OTHER

Exhaled VOC breath test

To determine longitudinal variation in exhaled VOC concentrations during intended curative therapy for EC cancer.

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • Benaroya Research Institute

    lead OTHER

Principal Investigators

  • Donald E Low, MD · Virginia Mason Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06453993 on ClinicalTrials.gov